A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Effect of Eszopiclone 2 mg on Sleep/Wake Function in Older Adults with Primary and Comorbid Insomnia
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Longer-term pharmacologic studies for insomnia in older individuals are sparse. OBJECTIVE: To evaluate the efficacy and safety of 12 weeks of nightly eszopiclone in elderly outpatients with insomnia. METHODS: Participants (65-85 years) met DSM-IV-TR criteria for insomnia with total sleep times (TST) < or = 6 h, and wake time after sleep onset (WASO) > or = 45 min. Participants were randomized to 12 weeks of eszopiclone 2 mg (n = 194) or placebo (n = 194), followed by a 2-week single-blind placebo run-out. Subject-reported measures of sleep (sTST, sleep latency [sSL], sWASO) and daytime function (alertness, concentration, wellbeing, ability to function) were assessed. AEs were monitored. RESULTS: Subjects treated with 2 mg eszopiclone slept longer at night on average and at every individual time point compared to baseline than placebo subjects, as measured by TST over the 12-week double-blind period (P < 0.0001). Mean sTST over the double-blind period for eszopiclone-treated subjects was 360.08 min compared to 297.86 min at baseline, a mean change of 63.24 min. Over the double-blind period, eszopiclone-treated subjects also experienced a significantly greater improvement in sSL compared to placebo, with a mean decrease of 24.62 min versus a mean decrease of 19.92 min, respectively (P = 0.0014). Eszopiclone subjects also experienced a significantly greater decrease in WASO (mean decrease of 36.4 min) compared to placebo subjects (decrease of 14.8 min) (P < 0.0001). Post-discontinuation, sleep parameters were statistically improved versus baseline for eszopiclone (P-values < or = 0.01), indicating no rebound. The most common AEs (> or = 5%) were headache (eszopiclone 13.9%, placebo 12.4%), unpleasant taste (12.4%, 1.5%), and nasopharyngitis (5.7%, 6.2%). CONCLUSION: In this Phase IV trial of older adults with insomnia, eszopiclone significantly improved patient-reported sleep and daytime function relative to placebo. Improvements occurred within the first week and were maintained for 3 months, with no evidence of rebound insomnia following discontinuation. The 12 weeks of treatment were well tolerated. CLINICAL TRIAL INFORMATION: A Long-Term Safety and Efficacy Study of Eszopiclone in Elderly Subjects With Primary Chronic Insomnia; Registration #NCT00386334; URL - http://www.clinicaltrials.gov/ct2/show/NCT00386334?term=eszopiclone&rank=24
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Validation of the Insomnia Severity Index as an outcome measure for insomnia research
Bastien, C. (2001) · Sleep Medicine · doi:10.1016/s1389-9457(00)00065-4 · Cited by 8,067
Sleep Complaints Among Elderly Persons: An Epidemiologic Study of Three Communities
Foley, D. J., Monjan, A. A., Brown, S. L., Simonsick, E. M., Wallace, R. B., & Blazer, D. G. (1995) · Sleep · doi:10.1093/sleep/18.6.425 · Cited by 1,610
Sheehan, D. V., Harnett-Sheehan, K., & Raj, B. A. (1996) · International Clinical Psychopharmacology · doi:10.1097/00004850-199606003-00015 · Cited by 1,440
Sleep disturbances and chronic disease in older adults
Foley, D., Ancoli-Israel, S., Britz, P., & Walsh, J. (2004) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2004.02.010 · Cited by 1,203
Insomnia and Its Treatment: Prevalence and Correlates
Mellinger, G. D. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790260019002 · Cited by 1,071
Krystal, A. D., Walsh, J. K., Laska, E., Caron, J., Amato, D. A., Wessel, T. C., & Roth, T. (2003) · Sleep · doi:10.1093/sleep/26.7.793 · Cited by 630
Self-citationHealthy Older Adults’ Sleep Predicts All-Cause Mortality at 4 to 19 Years of Follow-Up
Dew, M. A., Hoch, C. C., Buysse, D. J., Monk, T. H., Begley, A. E., Houck, P. R., Hall, M., Kupfer, D. J., & Reynolds, C. F. (2003) · Psychosomatic Medicine · doi:10.1097/01.psy.0000039756.23250.7c · Cited by 587
Goldman, S. E., Stone, K. L., Ancoli-Israel, S., Blackwell, T., Ewing, S. K., Boudreau, R., Cauley, J. A., Hall, M., Matthews, K. A., & Newman, A. B. (2007) · SLEEP · doi:10.1093/sleep/30.10.1317 · Cited by 277
Walsh, J. K., Krystal, A. D., Amato, D. A., Rubens, R., Caron, J., Wessel, T. C., Schaefer, K., Roach, J., Wallenstein, G., & Roth, T. (2007) · Sleep · doi:10.1093/sleep/30.8.959 · Cited by 239
Self-citationROTH, T., WALSH, J., KRYSTAL, A., WESSEL, T., & ROEHRS, T. (2005) · Sleep Medicine · doi:10.1016/j.sleep.2005.06.004 · Cited by 230
Self-citation
Research works printed but not linked: 29
- 1999, Characteristics of insomnia in the United States: results of the 1991 National Sleep Foundation Survey, I. Sleep, 22, S347
- 2005, Prevalence, associated risks, and treatment patterns of insomnia, J Clin Psychiatry, 66, 10
- 1999, Sleep Incidence and remission of insomnia among elderly adults: an epidemiologic study of 6,800 persons over three years, Sleep, 22, S366
- 2006, Sleep: a marker of physical and mental health in the elderly, Am J Geriatr Psychiatry, 14, 860, 10.1097/01.JGP.0000206164.56404.ba · DOI · Paper page
- 2008, Association between depressive symptoms and sleep disturbances in community-dwelling older men, J Am Geriatr Soc, 56, 1228, 10.1111/j.1532-5415.2008.01753.x · DOI · Paper page
- 2005, Normative sleep data, cognitive function and daily living activities in older adults in the community, Sleep, 28, 981
- 2001, The impact of insomnia on cognitive functioning in older adults, J Am Geriatr Soc, 49, 1185, 10.1046/j.1532-5415.2001.49235.x · DOI · Paper page
- 2006, Poor sleep is associated with impaired cognitive function in older women: the study of osteoporotic fractures, J Gerontol: Biol Sci Med Sci, 61, 405, 10.1093/gerona/61.4.405 · DOI · Paper page
- 2008, Association between sleep and physical function in older men: the osteoporotic fractures in men sleep study, J Am Geriatr Soc, 56, 1665, 10.1111/j.1532-5415.2008.01846.x · DOI · Paper page
- 2003, The problems of sleep for older women: changes in health outcomes, Age Ageing, 32, 123
- 2000, Insomnia in the elderly: a review for the primary care practitioner, Sleep, 23, S23
- 2005, Insomnia and hypnotic use, recorded in the minimum data set, as predictors of falls and hip fractures in Michigan nursing homes, J Am Geriatr Soc, 53, 955, 10.1111/j.1532-5415.2005.53304.x · DOI · Paper page
- 2008, Poor sleep is associated with increased risk of falls in older women, Arch Intern Med, 168, 1768, 10.1001/archinte.168.16.1768 · DOI · Paper page
- 2008, Sleep, insomnia and falls in elderly patients, Sleep Med, S1, S18
- 2008, Sleep duration associated with mortality in elderly, but not middle-aged, adults in a large US sample, Sleep, 31, 1087
- 2009, Self-reported sleep and nap habits and risk of mortality in a large cohort of older women, J Am Geriatr Soc, 57, 604, 10.1111/j.1532-5415.2008.02171.x · DOI · Paper page
- 2006, Insomnia comorbidity and impact and hypnotic use by age group in a national survey population aged 16 to 74 years, Sleep, 29, 1391, 10.1093/sleep/29.11.1391 · DOI · Paper page
- 1997, Longitudinal trends in late-life insomnia: implications for prescribing, Age Ageing, 26, 179, 10.1093/ageing/26.3.179 · DOI · Paper page
- 2009, A compendium of placebo-controlled trials of the risks/benefits of pharmacologic treatments for insomnia: the empirical basis for clinical practice, Sleep Med Rev, 13, 265, 10.1016/j.smrv.2008.08.001 · DOI · Paper page
- 2006, A polysomnography study of eszopiclone in elderly patients with insomnia, Curr Med Res Opin, 22, 1633, 10.1185/030079906X112741 · DOI · Paper page
- 2005, A 2-week efficacy and safety study of eszopiclone in elderly patients with primary insomnia, Sleep, 28, 720, 10.1093/sleep/28.6.720 · DOI · Paper page
- 1992, The MOS 36-Item short-form health survey (SF-36), Conceptual framework and item selection. Med Care, 30, 473
- 2007, Frequent napping is associated with excessive daytime sleepiness, depression, pain, and nocturia in older adults: findings from the National Sleep Foundation ‘2003 Sleep in America' Poll, Am J Geriatr Psychiatry, 15, 344, 10.1097/01.JGP.0000249385.50101.67 · DOI · Paper page
- 2008, Association between nighttime sleep and napping in older adults, Sleep, 31, 733, 10.1093/sleep/31.5.733 · DOI · Paper page
- 2006, Self-reported sleep and nap habits and risk of falls and fractures in older women: the study of osteoporotic fractures, J Am Geriatr Soc, 54, 1177, 10.1111/j.1532-5415.2006.00818.x · DOI · Paper page
- NIH State of the Science Conference statement on Manifestations and Management of Chronic Insomnia in Adults statement, 2005, J Clin Sleep Med, 1, 412, 10.5664/jcsm.26373 · DOI
- 2005, Prevalence and co-morbidity of insomnia and impact on functioning in elderly populations, J Am Geriatr Soc, 53, S264, 10.1111/j.1532-5415.2005.53392.x · DOI · Paper page
- 2007, Nightly treatment of primary insomnia with eszopiclone for six months: Effect on sleep, quality of life, and work limitations, Sleep, 30, 959, 10.1093/sleep/30.8.959 · DOI · Paper page
- 1999, Zaleplon, a novel nonbenzodiazepine hypnotic, effectively treats insomnia in elderly patients without causing rebound effects, Prim Care Companion J Clin Psychiatry, 1, 114, 10.4088/PCC.v01n0404 · DOI · Paper page
Cited by
European guideline for the diagnosis and treatment of insomnia
Riemann, D., Baglioni, C., Bassetti, C., Bjorvatn, B., Dolenc Groselj, L., Ellis, J. G., Espie, C. A., Garcia‐Borreguero, D., Gjerstad, M., Gonçalves, M., et al. (2017) · Journal of Sleep Research · doi:10.1111/jsr.12594 · Cited by 2,049
Qaseem, A., Kansagara, D., Forciea, M. A., Cooke, M., Denberg, T. D., & for the Clinical Guidelines Committee of the American College of Physicians* (2016) · Annals of Internal Medicine · doi:10.7326/m15-2175 · Cited by 1,965
“Older Population In older adults, low-quality evidence showed that eszopiclone improved remission, total sleep time, and wake after sleep onset (69).”
BackgroundSateia, M. J., Buysse, D. J., Krystal, A. D., Neubauer, D. N., & Heald, J. L. (2017) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.6470 · Cited by 1,519
Self-citationMorin, C. M., & Benca, R. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60750-2 · Cited by 976
Wilson, S., Nutt, D., Alford, C., Argyropoulos, S., Baldwin, D., Bateson, A., Britton, T., Crowe, C., Dijk, D.-J., Espie, C., et al. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881110379307 · Cited by 634
Self-citation
Metadata
- Authors
- Ancoli-lsrael, S., Krystal, A. D., McCall, W. V., Schaefer, K., Wilson, A., Claus, R., Rubens, R., & Roth, T.
- Venue
- Sleep
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-02
- Volume
- 33
- Issue
- 2
- Pages
- 225-234
- ISSN
- 0161-8105 (ISSN-L)
- 1550-9109
- OpenAlex
- W5483291
- Cited by
- 96
- References
- 11
- FWCI
- 9.59
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Effect of Eszopiclone 2 mg on Sleep/Wake Function in Older Adults with Primary and Comorbid Insomnia. https://app.cochat.ai/papers/10.1093/sleep/33.2.225
- The paper
- Ancoli-lsrael, S., Krystal, A. D., McCall, W. V., Schaefer, K., Wilson, A., Claus, R., Rubens, R., & Roth, T. (2010). A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Effect of Eszopiclone 2 mg on Sleep/Wake Function in Older Adults with Primary and Comorbid Insomnia. Sleep. https://doi.org/10.1093/sleep/33.2.225
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.